Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2157-2169
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2157
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2157
Figure 7 SMAD6 knockdown rescues the effects of Krüppel-like factor 16 overexpression on pancreatic adenocarcinoma.
(A) Protein levels of Krüppel-like factor (KLF)16 and SMAD6 in control (Ctrl), KLF16, and KLF16+shSAMD6 cells by western blotting in MIA PaCa-2 cells. GAPDH used as the internal control; B: Cell viability of Ctrl, KLF16, and KLF16+shSAMD6 cells by CCK-8 assay in MIA PaCa-2 cells; C: Protein levels of KLF16 and SMAD6 in siCtrl, siKLF16, and siKLF16+SAMD6 cells by western blotting in AsPC-1 cells. GAPDH used as the internal control; D: Cell viability of siCtrl, siKLF16, and siKLF16+SAMD6 cells by the CCK-8 assay in AsPC-1 cells; E: Tumor size from three groups of nude mice that were injection with MIA PaCa-2 cells transfected with Ctrl, KLF16, and KLF16+shSAMD6, separately; F: Tumor growth curve in three groups; G: Tumor weight among the three groups. NS: Not significant. bP < 0.01; cP < 0.001.
- Citation: Mi W, Zheng Z, Lu JD, Duan SQ, Zhang J, Zhang HQ, Ding YX, Yin J, Cao F, Zhang J, Li F. KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6. World J Gastrointest Oncol 2022; 14(11): 2157-2169
- URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2157.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2157